| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
BASIC SCIENCE |
Is Central to the Expression of the Renal Type II Na/Pi Co-transporter Gene and to the Regulation of Renal Phosphate Transport


*Minerva Center for Calcium and Bone Metabolism, Nephrology and Hypertension Services, The Hadassah Hebrew University Medical Center, Jerusalem, Israel; and
Department of Pediatrics, University of Cincinnati, Childrens Hospital Medical Center, Cincinnati, Ohio
Correspondence to Dr. Tally Naveh-Many, Nephrology Services, Hadassah Hospital, P.O. Box 12000, Jerusalem Israel 91120. Phone: +972-2-6776789; Fax: +972-2-6421234; E-mail: tally{at}cc.huji.ac.il
The sensing and response to extracellular phosphate (Pi) concentration is preserved from prokaryotes to mammals and ensures an adequate supply of Pi in the face of large differences in its availability. In mammals, the kidneys are central to Pi homeostasis. Renal Pi reabsorption is mediated by a Na/Pi co-transporter that is regulated by a renal Pi sensing system and humoral factors. The signal transduction by which Pi regulates type II Na/Pi activity is largely unknown. It is shown that calcineurin inhibitors specifically and dramatically decrease type II Na/Pi gene expression in a proximal tubule cell line and in vivo. Mice with genetic deletion of the calcineurin A
gene had a marked decrease in type II Na/Pi mRNA levels and remarkably did not show the expected increase in type II Na/Pi mRNA levels after the challenge of a low-Pi diet. In contrast, the regulation of renal 25(OH)-vitamin D 1
-hydroxylase gene expression by Pi was intact. This is the first demonstration that calcineurin has a crucial role in the signal transduction pathway regulating renal Pi homeostasis both in vitro and in vivo. These results suggest that the use of calcineurin inhibitors contributes to the renal Pi wasting seen in renal transplant patients.
This article has been cited by other articles:
![]() |
P. Evenepoel, B. K.I. Meijers, H. de Jonge, M. Naesens, B. Bammens, K. Claes, D. Kuypers, and Y. Vanrenterghem Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal Transplantation Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1829 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Levi, I. Z. Ben-Dov, V. Lavi-Moshayoff, M. Dinur, D. Martin, T. Naveh-Many, and J. Silver Increased Parathyroid Hormone Gene Expression in Secondary Hyperparathyroidism of Experimental Uremia Is Reversed by Calcimimetics: Correlation with Posttranslational Modification of the Trans Acting Factor AUF1 J. Am. Soc. Nephrol., January 1, 2006; 17(1): 107 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bell, E. Gaberman, R. Kilav, R. Levi, K. B. Cox, J. D. Molkentin, J. Silver, and T. Naveh-Many The Protein Phosphatase Calcineurin Determines Basal Parathyroid Hormone Gene Expression Mol. Endocrinol., February 1, 2005; 19(2): 516 - 526. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673